Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 1 6Phase 2 4Phase 3 3Phase 1/2 3Phase 2/3 1

Status

Completed 1277Terminated 412Unknown 364Recruiting 305Active not recruiting 186Withdrawn 111Not yet recruiting 95Enrolling by invitation 6Suspended 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 5Melanoma 5Carcinoma, Non-Small-Cell Lung 5Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Glioblastoma 4Breast Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Glioma 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Sarcoma 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Osteosarcoma 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Mesothelioma, Malignant 2Lymphoma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Diffuse Intrinsic Pontine Glioma 2Warts 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

taletrectinib 1Taxes 1Tamoxifen 1Tablets 1Paclitaxel 1Injections 1G(M1) Ganglioside 1Fluorouracil 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Suspended × Breast Neoplasms × Clear all
NCT05751668 2026-04-07

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Alliance for Clinical Trials in Oncology

Phase 2 Suspended
98 enrolled
Breast

Breast Neoplasms

NCT06214793 2025-05-01

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Case Comprehensive Cancer Center

Phase 2 Suspended
61 enrolled
Breast

Breast Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Suspended
170 enrolled
Breast

Breast Neoplasms

NCT00738777 2021-01-22

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

The Netherlands Cancer Institute

Phase 2 Suspended
250 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡